A share price of Repligen Corp [RGEN] is currently trading at $130.00, down -1.59%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RGEN shares have gain 12.86% over the last week, with a monthly amount drifted -10.27%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Repligen Corp [NASDAQ: RGEN] stock has seen the most recent analyst activity on March 18, 2025, when Evercore ISI initiated its In-line rating and assigned the stock a price target of $155. Previously, TD Cowen started tracking the stock with Buy rating on February 10, 2025, and set its price target to $200. On December 17, 2024, Canaccord Genuity initiated with a Hold rating and assigned a price target of $165 on the stock. Wolfe Research started tracking the stock assigning a Peer Perform rating. Wells Fargo initiated its recommendation with a Overweight and recommended $180 as its price target on August 28, 2024. Deutsche Bank upgraded its rating to Buy for this stock on June 26, 2024, and downed its price target to $155. In a note dated June 18, 2024, Guggenheim initiated an Neutral rating.
Repligen Corp experienced fluctuations in its stock price throughout the past year between $102.96 and $182.52. Currently, Wall Street analysts expect the stock to reach $220 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $130.00 at the most recent close of the market. An investor can expect a potential return of 69.23% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
Trailing Twelve Months sales for Repligen Corp [NASDAQ:RGEN] were 634.44M which represents 0.56% growth. Gross Profit Margin for this corporation currently stands at 0.49% with Operating Profit Margin at -0.07%, Pretax Profit Margin comes in at -0.05%, and Net Profit Margin reading is -0.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.01 and Total Capital is -0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.34.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 126.32 points at the first support level, and at 122.65 for the second support level. However, for the 1st resistance point, the stock is sitting at 132.59, and for the 2nd resistance point, it is at 135.19.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Repligen Corp [NASDAQ:RGEN] is 8.41. In addition, the Quick Ratio stands at 7.28 and the Cash Ratio stands at 5.97. Considering the valuation of this stock, the price to sales ratio is 11.51, the price to book ratio is 3.70.
Transactions by insiders
Recent insider trading involved Hunt Anthony, Director, that happened on Mar 17 ’25 when 26756.0 shares were sold. Director, Pax Margaret completed a deal on Mar 17 ’25 to buy 250.0 shares. Meanwhile, Director Hunt Anthony bought 26756.0 shares on Mar 17 ’25.
